Latest news for Epiroc (OTC:EPIAF) Stock

Epiroc is a global manufacturer of niche equipment and services used by mining and infrastructure customers. The company's products include hard rock drilling equipment and excavation technologies for underground and surface mining, as well as servicing and spare parts. Approximately 69% of group sales are from the aftermarket, which includes services and the sale of spare parts and consumables. Epiroc was spun out of Atlas Copco and listed as a stand-alone company on the Nasdaq Stockholm in June 2018.

Equities

News

Asset Sales

Markets

EPIROC AKTIEBOLAG SH AK A by EPIROC AKTIEBOLAG SHARE AK

EPIAF

EPOKY

Stanley Black &amp; Decker (NYSE: SWK) has agreed to divest its STANLEY Infrastructure division, which specializes in attachment and handheld hydraulic tools, to Epiroc AB (OTC: EPOKY) (OTC: 

Stanley Black &amp; Decker Streamlines Portfolio With $760M Infrastructure Sale To Epiroc, Targets Debt Reduction

EPIROC AKTIEBOLAG SH AK A by Epiroc Aktiebolag

Epiroc AB

Guidance

CSGP

CoStar Expects Q3 Revenue Of $692M - $697M (Est $677.261M), Representing Revenue Growth Of 11% Y/Y At Midpoint

Company to present pooled data from the pivotal Phase 2 TRUST-I and TRUST-II studies at the European Society of Medical Oncology (ESMO) Congress 2024, which will support Nuvation Bio's New Drug Application (NDA) in the United States
Company to present data from the global, pivotal Phase 2 TRUST-II study at the 2024 World Conference on Lung Cancer (WCLC)
Taletrectinib granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of ROS1-positive non-small cell lung cancer (NSCLC) and other NSCLC indications
Nuvation Bio Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUVB#NYSE">NUVB</a>), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced multiple updates for its taletrectinib program. Data from the global, pivotal Phase 2 TRUST-II study has been accepted for an oral presentation at WCLC 2024 taking place September 7-10 in San Diego, California. Pooled data from both pivotal Phase 2 studies, TRUST-I and TRUST-II, has been accepted for a poster presentation at ESMO 2024 taking place September 13-17, in Barcelona, Spain. The pooled data presented at ESMO will support the Company's NDA in the United States. Additionally, the U.S. FDA has granted Orphan Drug Designation to taletrectinib for the treatment of multiple NSCLC indications, including ROS1-positive NSCLC.

Biotech

General

NUVB

Nuvation Bio Announces Updates And Upcoming Presentations For Its ROS1 Inhibitor, Taletrectinib

East West Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>) reported quarterly earnings of $2.07 per share which beat the analyst consensus estimate of $1.97 by 5.08 percent. The company reported quarterly sales of $553.229 million which missed the analyst consensus estimate of $554.958 million by 0.31 percent. This is a 2.39 percent decrease over sales of $566.746 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

EWBC

East West Bancorp Q2 2024 Adj EPS $2.07 Beats $1.97 Estimate, Sales $553.229M Miss $554.958M Estimate

Vicor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VICR#NASDAQ">VICR</a>) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $0.05 by 160 percent. This is a 107.89 percent decrease over earnings of $0.38 per share from the same period last year. The company reported quarterly sales of $85.854 million which beat the analyst consensus estimate of $81.767 million by 5.00 percent. This is a 19.57 percent decrease over sales of $106.747 million the same period last year.

VICR

Vicor Q2 2024 GAAP EPS $(0.03) Misses $0.05 Estimate, Sales $85.854M Beat $81.767M Estimate

Euroseas Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESEA#NASDAQ">ESEA</a>, the "Company" or "Euroseas")))), an owner and operator of container carrier vessels and provider of seaborne transportation for containerized cargoes, announced today a new time charter contract for its 1,740 feeder containership, EM Spetses, for a minimum period of 18 to a maximum period of 20 months at the option of the charterer, at a gross daily rate of $18,100. The charter for EM Spetses will commence in early August 2024, upon the completion of its current charter.

Contracts

ESEA

Euroseas Announces 18-Month Charter Contract For Its Feeder Containership, EM Spetses, At A Gross Daily Rate Of $18,100

Canadian National Railway Q2 Adj. EPS C$1.84 Up From C$1.76 YoY; Revenue C$4.329B Up From C$4.057B YoY

TSLA

Tesla Says 'Plans for new vehicles, including more affordable models, remain on track for start of production in the first half of 2025.'

First Community (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCBC#NASDAQ">FCBC</a>) reported quarterly earnings of $0.79 per share which beat the analyst consensus estimate of $0.63 by 25.4 percent. This is a 12.86 percent increase over earnings of $0.70 per share from the same period last year.

FCBC

First Community Q2 Adj $0.79 Beats $0.63 Estimate

WIIM

Tesla shares are trading lower following Q2 earnings.

Red Rock Resorts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RRR#NASDAQ">RRR</a>) reported quarterly earnings of $0.59 per share which missed the analyst consensus estimate of $0.66 by 10.61 percent. This is a 9.23 percent decrease over earnings of $0.65 per share from the same period last year. The company reported quarterly sales of $486.40 million which beat the analyst consensus estimate of $475.59 million by 2.27 percent. This is a 16.89 percent increase over sales of $416.13 million the same period last year.

Red Rock Resorts Q2 Adj $0.59 Misses $0.66 Estimate, Sales $486.40M Beat $475.59M Estimate

Tesla Says Q2 Revenue Increase Was Due To energy Generation And Storage Growth, Cybertruck Deliveries And Higher Regulatory Growth Revenue

Agree Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADC#NYSE">ADC</a>) reported quarterly Adjusted FFO of $1.04 per share which beat the analyst consensus estimate of $1.02 by 1.96 percent. This is a 6.12 percent increase over earnings of $0.98 per share from the same period last year. The company reported quarterly sales of $152.575 million which beat the analyst consensus estimate of $147.854 million by 3.19 percent. This is a 17.46 percent increase over sales of $129.900 million the same period last year.

Agree Realty Q2 2024 Adjusted FFO $1.04 Beats $1.02 Estimate, Sales $152.575M Beat $147.854M Estimate

Highwoods Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIW#NYSE">HIW</a>) reported quarterly earnings of $0.98 per share which beat the analyst consensus estimate of $0.90 by 8.89 percent. The company reported quarterly sales of $204.73 million which missed the analyst consensus estimate of $205.07 million by 0.16 percent. This is a 1.24 percent decrease over sales of $207.29 million the same period last year.

Highwoods Props Q2 2024 FFO $0.98 Beats $0.90 Estimate, Sales $204.73M Miss $205.07M Estimate

Visa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) reported quarterly earnings of $2.42 per share which met the analyst consensus estimate. The company reported quarterly sales of $8.90 billion which missed the analyst consensus estimate of $8.92 billion by 0.18 percent. This is a 9.57 percent increase over sales of $8.12 billion the same period last year.

Visa Q3 2024 GAAP EPS $2.42, Inline, Sales $8.90B Miss $8.92B Estimate

Capital One Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>) reported quarterly earnings of $3.14 per share which missed the analyst consensus estimate of $3.29 by 4.56 percent. This is a 10.8 percent decrease over earnings of $3.52 per share from the same period last year. The company reported quarterly sales of $9.51 billion which missed the analyst consensus estimate of $9.57 billion by 0.67 percent. This is a 5.48 percent increase over sales of $9.01 billion the same period last year.

Capital One Finl Q2 Adj $3.14 Misses $3.29 Estimate, Sales $9.51B Miss $9.57B Estimate

Nabors Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBR#NYSE">NBR</a>) reported quarterly losses of $(4.29) per share. The company reported quarterly sales of $742.979 million which beat the analyst consensus estimate of $739.250 million by 0.50 percent. This is a 4.60 percent decrease over sales of $778.810 million the same period last year.

Nabors Industries Q2 2024 GAAP EPS $(4.29), Sales $742.979M Beat $739.250M Estimate

Tesla Says 'In 2024, the growth rates of energy storage deployments and
revenue in our Energy Generation and Storage business should outpace the Automotive business.'

Tesla Sees 2024 Vehicle Volume Growth Lower Than 2023 Due To Launch Of Next-Generation Vehicles

THIRD QUARTER 2024 FINANCIAL OUTLOOK
For the third quarter of 2024, Enphase Energy estimates both GAAP and non-GAAP financial results as follows:
<ul>
<li>Revenue to be within a range of $370.0 million to $410.0 million, which includes shipments of 160 to 180 megawatt hours of IQ Batteries</li>
<li>GAAP gross margin to be within a range of 45.0% to 48.0% with net IRA benefit</li>
<li>Non-GAAP gross margin to be within a range of 47.0% to 50.0% with net IRA benefit and 39.0% to 42.0% excluding net IRA benefit. Non-GAAP gross margin excludes stock-based compensation expense and acquisition related amortization</li>
<li>Net IRA benefit to be within a range of $30.0 million to $33.0 million based on estimated shipments of 1,100,000 units of U.S. manufactured microinverters</li>
<li>GAAP operating expenses to be within a range of $138.0 million to $142.0 million</li>
<li>Non-GAAP operating expenses to be within a range of $79.0 million to $83.0 million, excluding $59.0 million estimated for stock-based compensation expense, acquisition related amortization and restructuring</li>
</ul>
For 2024, GAAP and non-GAAP annualized effective tax rate with IRA benefit, excluding discrete items, is expected to be within a range of 17.0% to 19.0%.

ENPH

Enphase Energy Sees Q3 Revenue $370M-$410M Vs $404.63M Est.; For 2024, GAAP And Non-GAAP Annualized Effective Tax Rate With IRA Benefit, Excluding Discrete Items, Is Expected To Be Within A Range Of 17%-19%

CoStar Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSGP#NASDAQ">CSGP</a>) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0.09 by 66.67 percent. This is a 51.61 percent decrease over earnings of $0.31 per share from the same period last year. The company reported quarterly sales of $677.800 million which beat the analyst consensus estimate of $677.647 million by 0.02 percent. This is a 11.87 percent increase over sales of $605.906 million the same period last year.

CoStar Q2 2024 Adj EPS $0.15 Beats $0.09 Estimate, Sales $677.800M Beat $677.647M Estimate

Epiroc AB (publ) 2023 Q3 - Results - Earnings Call Presentation

Epiroc AB (publ) (EPOKY) Q3 2023 Earnings Call Transcript

Atlas Copco: This Is A Good Time To Sell The Shares (Rating Downgrade)

Epiroc AB (publ) (EPOKY) Q4 2023 Earnings Call Transcript

Epiroc AB (publ) (EPOKY) Q1 2024 Earnings Call Transcript

Harding Loevner International Equity Composite Q1 2024 Report

Harding Loevner International Developed Markets Equity Composite Q1 2024 Report

Investors Seem Unbothered By A Potential Cyclical Decline In Komatsu's Business

Epiroc AB (publ) (EPOKY) Q2 2024 Earnings Call Transcript

Epiroc AB (publ) 2024 Q2 - Results - Earnings Call Presentation

AAGIY

AAIGF

ABBNY

ABLZF

ADYEY

ADYYF

ALFVF

ALFVY

ASAZF

ASAZY

ASML

ASMLF

ATLCY

ATLFF

ATLKY

ATLPF

BBVA

BBVXF

BHPLF

BNTX

DAIUF

DASTF

DASTY

DFKCY

EPIPF

GOOG

GOOGL

IFNNF

IFNNY

KMTUF

KMTUY

LVMHF

LVMUY

MORN

NHNCF

NONOF

RHHBF

RHHBY

RHHVF

RTNTF

RTPPF

SAPGF

SBGSF

SBGSY

SDVKF

SDVKY

SNEJF

SONY

SPGI

SSNLF

TOYOF

TSMWF

Epiroc

Stanley Black &amp; Decker&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SWK#NYSE">SWK</a>) has agreed to divest its STANLEY Infrastructure division, which specializes in attachment and handheld hydraulic tools, to&nbsp;Epiroc AB&nbsp;(OTC:<a class="ticker" href="https://www.benzinga.com/stock/EPOKY#OTC">EPOKY</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/EPIAF#OTC">EPIAF</a>) <a href="https://www.benzinga.com/pressreleases/23/12/n36255569/stanley-black-decker-announces-agreement-to-sell-attachment-tools-business">for $760 million in cash.</a>

The Infrastructure division is projected to yield revenues in the range of $450 million to $470 million in FY23, with an anticipated EBITDA margin hovering between the mid to high teens; the divestiture of the Infrastructure division is perceived as a strategic advancement for Stanley Black &amp; Decker.

The company plans to use the net proceeds from this transaction, after minimal taxes, to reduce its debt burden.

Stanley Black &amp; Decker anticipates a pre-tax, non-cash charge ranging from $100 million to $150 million. This charge, stemming from the write-down of Infrastructure&#39;s net assets, will be excluded from the company&#39;s adjusted earnings.&nbsp;

Price Action: SWK shares traded down 0.76% at $100.72&nbsp;on the last check Friday.

Disclaimer: This content was partially produced with the help of AI tools and was Reviewed And Published By Benzinga Editors.

Photo via Company

Stanley Black & Decker Streamlines Portfolio With $760M Infrastructure Sale To Epiroc, Targets Debt Reduction

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Epiroc

News

Latest news for Epiroc (OTC:EPIAF) Stock

Friday, December 15, 2023